Aces for Autism
Analysis
Aces for Autism is a registered charity in United States, based in Greenville, NC. It received its IRS tax-exemption ruling in March 2015, 11 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, Aces for Autism reported income of $9.3m and spending of $3.1m, leaving 66% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $2.4m to $9.3m (+285%), an average of +40% a year. The sharpest change came in the year to December 2023, when income rose by 157%. Over the whole period it spent 50% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Aces for Autism sits at the 83rd percentile: it is larger than about 83% of them. Against every charity in United States with reported income it ranks in the 95th percentile, and in the 96th percentile within NC. Charities of a similar size with the same main cause include Farnham Inc ($9.3m), American College of Endocrinology Inc ($9.3m) and Partners for Health Inc ($9.3m).
On its Form 990 for the period ending December 2023, revenue came from contributions and grants 59% and program service revenue 38% of the total. Other salaries and wages came to $2.0m. At year end it held assets of $19.2m against liabilities of $7.6m, net assets of $11.6m. It reported 134 employees.
Income and spending
Where the income comes from
- Contributions & grants 59%
- Program services 38%
- Other 3.4%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Farnham Inc | Oswego | $9.3m |
| American College of Endocrinology Inc | Jacksonville | $9.3m |
| Partners for Health Inc | Montclair | $9.3m |
| FLH Medical PC | Geneva | $9.3m |